Cas:51-40-1 Noradrenaline tartrate manufacturer & supplier

Chemical Name:Noradrenaline tartrate

CAS.NO:51-40-1

Synonyms:Norepinephrine Bitartrate;l-noradrenalinetartrate;noradrenaline bitartrate;Levarterenolbitartrate;MFCD00036384;4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol 2,3-dihydroxysuccinate (1:1);Leverterenol bitartrate;noradrenalinetartrate;4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol 2,3-dihydroxysuccinate (1:1);1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, 2,3-dihydroxybutanedioate (1:1) (salt);L-ARTERENOL BITARTRATE;Noradrenalineacidtartrate;4-(2-amino-1-hydroxyethyl)benzene-1,2-diol 2,3-dihydroxybutanedioate (1:1);NORADRENALINE;EINECS 200-095-0;Levoarterenol bitartrate

Molecular Formula:C₁₂H₁₇NO₉

Molecular Weight:319.265

HS Code:2922210000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:442.6ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:201.77000

Exact Mass:319.090332

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3249

Packing Group:III

Contact us for information like Norepinephrine Bitartrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Levoarterenol bitartrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00036384 Use and application,noradrenaline bitartrate technical grade,usp/ep/jp grade.

Related News: The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. Noradrenaline tartrate manufacturer If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role. Noradrenaline tartrate supplier The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. Noradrenaline tartrate vendor AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. Noradrenaline tartrate factory AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment.